CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 120 filers reported holding CARA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $94,000 | -47.8% | 5,789 | -41.2% | 0.00% | 0.0% |
| Q3 2019 | $180,000 | -6.2% | 9,845 | +10.1% | 0.00% | 0.0% |
| Q2 2019 | $192,000 | -37.3% | 8,945 | -42.7% | 0.00% | -66.7% |
| Q1 2019 | $306,000 | +45.0% | 15,602 | -4.3% | 0.00% | +50.0% |
| Q4 2018 | $211,000 | -49.4% | 16,297 | -6.7% | 0.00% | -50.0% |
| Q3 2018 | $417,000 | +50.0% | 17,467 | +20.3% | 0.00% | 0.0% |
| Q2 2018 | $278,000 | +72.7% | 14,519 | +11.9% | 0.00% | +100.0% |
| Q1 2018 | $161,000 | +96.3% | 12,976 | +91.2% | 0.00% | +100.0% |
| Q4 2017 | $82,000 | -24.8% | 6,786 | -14.4% | 0.00% | -50.0% |
| Q3 2017 | $109,000 | +12.4% | 7,931 | +25.3% | 0.00% | 0.0% |
| Q2 2017 | $97,000 | -7.6% | 6,330 | +10.3% | 0.00% | 0.0% |
| Q1 2017 | $105,000 | +337.5% | 5,741 | +125.2% | 0.00% | +100.0% |
| Q4 2016 | $24,000 | – | 2,549 | +5564.4% | 0.00% | – |
| Q3 2016 | $0 | – | 45 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
| Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
| Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
| Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
| DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
| Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
| AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
| ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |